Human Gene CALR (ENST00000316448.10_6) from GENCODE V47lift37

Home
Genomes
Genome Browser
Tools
Mirrors
- Euro/Asia Mirrors
- Mirroring Instructions
- US Server
- European Server
- Asian Server
Downloads
My Data
Projects
Help
About Us
- News
- Cite Us
- Release Log
- Staff
- Conditions of Use
- Our History
- Licenses
- Contact Us

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3

MalaCards Gene Search: CALR
Diseases sorted by gene-association score: myelofibrosis with myeloid metaplasia, somatic* (961), essential thrombocythemia* (550), thrombocythemia 1* (520), calr-related essential thrombocythemia* (100), breast mucinous carcinoma (22), rubella (20), heart block, congenital (16), myeloperoxidase deficiency (13), myeloproliferative neoplasm (11), juvenile astrocytoma (10), maxillary sinus squamous cell carcinoma (10), budd-chiari syndrome (8), necatoriasis (7), chronic neutrophilic leukemia (7), onchocerciasis (7), chagas disease (7), polycythemia (6), catecholaminergic polymorphic ventricular tachycardia (6), trypanosomiasis (5), lupus erythematosus (5), intestinal volvulus (5), taeniasis (5), systemic lupus erythematosus (4), myopathy, tubular aggregate, 1 (3), thrombocytopenia-absent radius syndrome (3), celiac disease (3), dilated cardiomyopathy (1)
* = Manually curated disease association

The following chemicals interact with this gene

D004997 Ethinyl Estradiol
D013749 Tetrachlorodibenzodioxin
C114369 7,8-diacetoxy-4-methylcoumarin
D000082 Acetaminophen
D001564 Benzo(a)pyrene
D003042 Cocaine
D016572 Cyclosporine
D005485 Flutamide
D005839 Gentamicins
D006861 Hydrogen Peroxide
D013629 Tamoxifen
D013739 Testosterone
D014415 Tunicamycin
D014635 Valproic Acid
C023036 perfluorooctanoic acid
C006253 pirinixic acid
D020122 tert-Butylhydroperoxide
C028474 1,4-bis(2-(3,5-dichloropyridyloxy))benzene
C063002 2,3-dimethoxy-1,4-naphthoquinone
C016403 2,4-dinitrotoluene
C050224 3,5,5-trimethylhexanoylferrocene
C017906 3-dinitrobenzene
C009505 4,4'-diaminodiphenylmethane
C032078 4-methylumbelliferyl acetate
C477187 5-(4-methylpiperazin-1-yl)-2-(2'-(3,4-dimethoxyphenyl)-5'-benzimidazolyl)benzimidazole
D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
D015124 8-Bromo Cyclic Adenosine Monophosphate
D015127 9,10-Dimethyl-1,2-benzanthracene
D000643 Ammonium Chloride
D000667 Ampicillin
C423844 BL 11282
D003994 Bucladesine
D002104 Cadmium
D002118 Calcium
D002509 Cephaloridine
D002746 Chlorpromazine
D004390 Chlorpyrifos
D002784 Cholesterol
D002794 Choline
D002857 Chromium
D002867 Chromones
D002945 Cisplatin
D002994 Clofibrate
D002995 Clofibric Acid
D003300 Copper
D019327 Copper Sulfate
D003520 Cyclophosphamide
D003976 Diazinon
D003993 Dibutyl Phthalate
D004008 Diclofenac
D004026 Dieldrin
D004052 Diethylnitrosamine
D004054 Diethylstilbestrol
D004147 Dioxins
D004317 Doxorubicin
D004610 Ellagic Acid
D017313 Fenretinide
D005411 Flame Retardants
D005492 Folic Acid
D005944 Glucosamine
D005947 Glucose
D006221 Halothane
D006820 Hyaluronic Acid
D007460 Iodoacetamide
D015759 Ionomycin
D007501 Iron
D007545 Isoproterenol
D001556 Lindane
D008094 Lithium
D008095 Lithocholic Acid
D008148 Lovastatin
C540575 MK2i peptide
D008627 Mercuric Chloride
D008628 Mercury
D008715 Methionine
D008727 Methotrexate
D008942 Mitoxantrone
D009538 Nicotine
D009569 Nitric Oxide
D016627 Oxidopamine
D010634 Phenobarbital
D011192 Potassium Dichromate
D011374 Progesterone
C513635 S-2-pentyl-4-pentynoic hydroxamic acid
D012643 Selenium
D053260 Soot
C041711 St. Thomas' Hospital cardioplegic solution
D013311 Streptozocin
D013755 Tetradecanoylphorbol Acetate
D013759 Tetrahydrocannabinol
D019284 Thapsigargin
D014028 Tobacco Smoke Pollution
D014212 Tretinoin
D014241 Trichloroethylene
D014266 Trientine
D014810 Vitamin E
D014859 Warfarin
D015032 Zinc
C006632 arsenic trioxide
C095105 bexarotene
C006780 bisphenol A
C059041 calyculin A
C018021 cobaltous chloride
C007420 dihydroxyaluminum aminoacetate
C108373 dutasteride
C504383 fenbuconazole
C027235 gallium nitrate
C428264 indioside D
C011890 kojic acid
C008261 lead acetate
C028007 nickel monoxide
C086401 pentabromodiphenyl ether
C035988 procymidone
C059514 resveratrol
C496827 salubrinal
C017947 sodium arsenite
C059873 sulfamethoxazole hydroxylamine
C053079 tautomycin
C009495 titanium dioxide
C025643 vinclozolin
C111237 vorinostat

Press "+" in the title bar above to open this section.

Highest median expression: 578.29 RPKM in Thyroid
Total median expression: 8864.06 RPKM

View in GTEx track of Genome Browser View at GTEx portal View GTEx Body Map

Press "+" in the title bar above to open this section.

BC072002 - Homo sapiens calreticulin, mRNA (cDNA clone IMAGE:6262525), **** WARNING: chimeric clone ****.
LF208184 - JP 2014500723-A/15687: Polycomb-Associated Non-Coding RNAs.
LF373332 - JP 2014500723-A/180835: Polycomb-Associated Non-Coding RNAs.
M84739 - Human autoantigen calreticulin mRNA, complete cds.
AK295230 - Homo sapiens cDNA FLJ53009 complete cds, highly similar to Calreticulin precursor.
AK304492 - Homo sapiens cDNA FLJ58668 complete cds, highly similar to Calreticulin precursor.
FJ224311 - Homo sapiens epididymis secretory sperm binding protein Li 99n (HEL-S-99n) mRNA, complete cds.
M32294 - Human Ro ribonucleoprotein autoantigen (Ro/SS-A), complete cds.
BC007911 - Homo sapiens calreticulin, mRNA (cDNA clone MGC:14363 IMAGE:4299303), complete cds.
BC020493 - Homo sapiens calreticulin, mRNA (cDNA clone MGC:10100 IMAGE:3898550), complete cds.
GQ900919 - Homo sapiens clone HEL-T-31 epididymis secretory sperm binding protein mRNA, complete cds.
BC052621 - Homo sapiens cDNA clone IMAGE:6578175, **** WARNING: chimeric clone ****.
AY047586 - Homo sapiens calreticulin (CALR) mRNA, complete cds.
BC002500 - Homo sapiens calreticulin, mRNA (cDNA clone MGC:2227 IMAGE:3050717), complete cds.
AB385014 - Synthetic construct DNA, clone: pF1KB5014, Homo sapiens CALR gene for calreticulin precursor, complete cds, without stop codon, in Flexi system.
KJ890816 - Synthetic construct Homo sapiens clone ccsbBroadEn_00210 CALR gene, encodes complete protein.
CR457070 - Homo sapiens full open reading frame cDNA clone RZPDo834G0511D for gene CALR, calreticulin; complete cds, incl. stopcodon.
AB451408 - Homo sapiens CALR mRNA for calreticulin precursor, partial cds, clone: FLJ08113AAAF.
BT007448 - Homo sapiens calreticulin mRNA, complete cds.
LP633929 - Sequence 147 from Patent WO2015036599.
LP633933 - Sequence 151 from Patent WO2015036599.
LP633937 - Sequence 155 from Patent WO2015036599.
LP633941 - Sequence 159 from Patent WO2015036599.
LP633945 - Sequence 163 from Patent WO2015036599.
LP633949 - Sequence 167 from Patent WO2015036599.
LP633953 - Sequence 171 from Patent WO2015036599.
LP633957 - Sequence 175 from Patent WO2015036599.
LP633961 - Sequence 179 from Patent WO2015036599.
LP633965 - Sequence 183 from Patent WO2015036599.
LP633969 - Sequence 187 from Patent WO2015036599.
LP633973 - Sequence 191 from Patent WO2015036599.
LP633977 - Sequence 195 from Patent WO2015036599.
LP633981 - Sequence 199 from Patent WO2015036599.
LP633985 - Sequence 203 from Patent WO2015036599.
LP633989 - Sequence 207 from Patent WO2015036599.
LP633993 - Sequence 211 from Patent WO2015036599.
LP633997 - Sequence 215 from Patent WO2015036599.
LP634001 - Sequence 219 from Patent WO2015036599.
LP634005 - Sequence 223 from Patent WO2015036599.
LP634009 - Sequence 227 from Patent WO2015036599.
LP634013 - Sequence 231 from Patent WO2015036599.
LP634017 - Sequence 235 from Patent WO2015036599.
LP634021 - Sequence 239 from Patent WO2015036599.
LP634025 - Sequence 243 from Patent WO2015036599.
LP634029 - Sequence 247 from Patent WO2015036599.
LP634033 - Sequence 251 from Patent WO2015036599.
LP634037 - Sequence 255 from Patent WO2015036599.
LP634041 - Sequence 259 from Patent WO2015036599.
LP634045 - Sequence 263 from Patent WO2015036599.
LP634049 - Sequence 267 from Patent WO2015036599.
LP634053 - Sequence 271 from Patent WO2015036599.
LP634057 - Sequence 275 from Patent WO2015036599.
LP634061 - Sequence 279 from Patent WO2015036599.
LP634065 - Sequence 283 from Patent WO2015036599.
LP634069 - Sequence 287 from Patent WO2015036599.
LQ447312 - Sequence 147 from Patent EP3020727.
LQ447316 - Sequence 151 from Patent EP3020727.
LQ447320 - Sequence 155 from Patent EP3020727.
LQ447324 - Sequence 159 from Patent EP3020727.
LQ447328 - Sequence 163 from Patent EP3020727.
LQ447332 - Sequence 167 from Patent EP3020727.
LQ447336 - Sequence 171 from Patent EP3020727.
LQ447340 - Sequence 175 from Patent EP3020727.
LQ447344 - Sequence 179 from Patent EP3020727.
LQ447348 - Sequence 183 from Patent EP3020727.
LQ447352 - Sequence 187 from Patent EP3020727.
LQ447356 - Sequence 191 from Patent EP3020727.
LQ447360 - Sequence 195 from Patent EP3020727.
LQ447364 - Sequence 199 from Patent EP3020727.
LQ447368 - Sequence 203 from Patent EP3020727.
LQ447372 - Sequence 207 from Patent EP3020727.
LQ447376 - Sequence 211 from Patent EP3020727.
LQ447380 - Sequence 215 from Patent EP3020727.
LQ447384 - Sequence 219 from Patent EP3020727.
LQ447388 - Sequence 223 from Patent EP3020727.
LQ447392 - Sequence 227 from Patent EP3020727.
LQ447396 - Sequence 231 from Patent EP3020727.
LQ447400 - Sequence 235 from Patent EP3020727.
LQ447404 - Sequence 239 from Patent EP3020727.
LQ447408 - Sequence 243 from Patent EP3020727.
LQ447412 - Sequence 247 from Patent EP3020727.
LQ447416 - Sequence 251 from Patent EP3020727.
LQ447420 - Sequence 255 from Patent EP3020727.
LQ447424 - Sequence 259 from Patent EP3020727.
LQ447428 - Sequence 263 from Patent EP3020727.
LQ447432 - Sequence 267 from Patent EP3020727.
LQ447436 - Sequence 271 from Patent EP3020727.
LQ447440 - Sequence 275 from Patent EP3020727.
LQ447444 - Sequence 279 from Patent EP3020727.
LQ447448 - Sequence 283 from Patent EP3020727.
LQ447452 - Sequence 287 from Patent EP3020727.
LQ789314 - Sequence 147 from Patent EP3339318.
LQ789318 - Sequence 151 from Patent EP3339318.
LQ789322 - Sequence 155 from Patent EP3339318.
LQ789326 - Sequence 159 from Patent EP3339318.
LQ789330 - Sequence 163 from Patent EP3339318.
LQ789334 - Sequence 167 from Patent EP3339318.
LQ789338 - Sequence 171 from Patent EP3339318.
LQ789342 - Sequence 175 from Patent EP3339318.
LQ789346 - Sequence 179 from Patent EP3339318.
LQ789350 - Sequence 183 from Patent EP3339318.
LQ789354 - Sequence 187 from Patent EP3339318.
LQ789358 - Sequence 191 from Patent EP3339318.
LQ789362 - Sequence 195 from Patent EP3339318.
LQ789366 - Sequence 199 from Patent EP3339318.
LQ789370 - Sequence 203 from Patent EP3339318.
LQ789374 - Sequence 207 from Patent EP3339318.
LQ789378 - Sequence 211 from Patent EP3339318.
LQ789382 - Sequence 215 from Patent EP3339318.
LQ789386 - Sequence 219 from Patent EP3339318.
LQ789390 - Sequence 223 from Patent EP3339318.
LQ789394 - Sequence 227 from Patent EP3339318.
LQ789398 - Sequence 231 from Patent EP3339318.
LQ789402 - Sequence 235 from Patent EP3339318.
LQ789406 - Sequence 239 from Patent EP3339318.
LQ789410 - Sequence 243 from Patent EP3339318.
LQ789414 - Sequence 247 from Patent EP3339318.
LQ789418 - Sequence 251 from Patent EP3339318.
LQ789422 - Sequence 255 from Patent EP3339318.
LQ789426 - Sequence 259 from Patent EP3339318.
LQ789430 - Sequence 263 from Patent EP3339318.
LQ789434 - Sequence 267 from Patent EP3339318.
LQ789438 - Sequence 271 from Patent EP3339318.
LQ789442 - Sequence 275 from Patent EP3339318.
LQ789446 - Sequence 279 from Patent EP3339318.
LQ789450 - Sequence 283 from Patent EP3339318.
LQ789454 - Sequence 287 from Patent EP3339318.
LV525549 - JP 2016537012-A/111: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525552 - JP 2016537012-A/114: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525555 - JP 2016537012-A/117: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525558 - JP 2016537012-A/120: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525561 - JP 2016537012-A/123: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525564 - JP 2016537012-A/126: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525567 - JP 2016537012-A/129: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525570 - JP 2016537012-A/132: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525573 - JP 2016537012-A/135: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525576 - JP 2016537012-A/138: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525579 - JP 2016537012-A/141: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525582 - JP 2016537012-A/144: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525585 - JP 2016537012-A/147: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525588 - JP 2016537012-A/150: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525591 - JP 2016537012-A/153: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525594 - JP 2016537012-A/156: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525597 - JP 2016537012-A/159: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525600 - JP 2016537012-A/162: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525603 - JP 2016537012-A/165: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525606 - JP 2016537012-A/168: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525609 - JP 2016537012-A/171: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525612 - JP 2016537012-A/174: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525615 - JP 2016537012-A/177: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525618 - JP 2016537012-A/180: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525621 - JP 2016537012-A/183: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525624 - JP 2016537012-A/186: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525627 - JP 2016537012-A/189: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525630 - JP 2016537012-A/192: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525633 - JP 2016537012-A/195: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525636 - JP 2016537012-A/198: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525639 - JP 2016537012-A/201: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525642 - JP 2016537012-A/204: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525645 - JP 2016537012-A/207: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525648 - JP 2016537012-A/210: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525651 - JP 2016537012-A/213: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525654 - JP 2016537012-A/216: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289264 - KR 1020160068754-A/147: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289267 - KR 1020160068754-A/151: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289270 - KR 1020160068754-A/155: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289273 - KR 1020160068754-A/159: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289276 - KR 1020160068754-A/163: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289279 - KR 1020160068754-A/167: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289282 - KR 1020160068754-A/171: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289285 - KR 1020160068754-A/175: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289288 - KR 1020160068754-A/179: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289291 - KR 1020160068754-A/183: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289294 - KR 1020160068754-A/187: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289297 - KR 1020160068754-A/191: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289300 - KR 1020160068754-A/195: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289303 - KR 1020160068754-A/199: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289306 - KR 1020160068754-A/203: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289309 - KR 1020160068754-A/207: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289312 - KR 1020160068754-A/211: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289315 - KR 1020160068754-A/215: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289318 - KR 1020160068754-A/219: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289321 - KR 1020160068754-A/223: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289324 - KR 1020160068754-A/227: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289327 - KR 1020160068754-A/231: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289330 - KR 1020160068754-A/235: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289333 - KR 1020160068754-A/239: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289336 - KR 1020160068754-A/243: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289339 - KR 1020160068754-A/247: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289342 - KR 1020160068754-A/251: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289345 - KR 1020160068754-A/255: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289348 - KR 1020160068754-A/259: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289351 - KR 1020160068754-A/263: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289354 - KR 1020160068754-A/267: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289357 - KR 1020160068754-A/271: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289360 - KR 1020160068754-A/275: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289363 - KR 1020160068754-A/279: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289366 - KR 1020160068754-A/283: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289369 - KR 1020160068754-A/287: Mutant calreticulin for the diagnosis of myeloid malignancies.
AK223060 - Homo sapiens mRNA for calreticulin precursor variant, clone: JTH13773.
LF373331 - JP 2014500723-A/180834: Polycomb-Associated Non-Coding RNAs.
AF087986 - Homo sapiens full length insert cDNA clone YX19H04.
LF373329 - JP 2014500723-A/180832: Polycomb-Associated Non-Coding RNAs.
LF373328 - JP 2014500723-A/180831: Polycomb-Associated Non-Coding RNAs.
LF373327 - JP 2014500723-A/180830: Polycomb-Associated Non-Coding RNAs.
LF373326 - JP 2014500723-A/180829: Polycomb-Associated Non-Coding RNAs.
LF373325 - JP 2014500723-A/180828: Polycomb-Associated Non-Coding RNAs.
AK130190 - Homo sapiens cDNA FLJ26680 fis, clone MPG04548, highly similar to Calreticulin precursor.
DL492170 - Novel nucleic acids.
LF373324 - JP 2014500723-A/180827: Polycomb-Associated Non-Coding RNAs.
LF373323 - JP 2014500723-A/180826: Polycomb-Associated Non-Coding RNAs.
LF373322 - JP 2014500723-A/180825: Polycomb-Associated Non-Coding RNAs.
LP634075 - Sequence 293 from Patent WO2015036599.
LP634079 - Sequence 297 from Patent WO2015036599.
LP634083 - Sequence 301 from Patent WO2015036599.
LP634087 - Sequence 305 from Patent WO2015036599.
LP634091 - Sequence 309 from Patent WO2015036599.
LP634095 - Sequence 313 from Patent WO2015036599.
LP634099 - Sequence 317 from Patent WO2015036599.
LP634103 - Sequence 321 from Patent WO2015036599.
LP634107 - Sequence 325 from Patent WO2015036599.
LP634111 - Sequence 329 from Patent WO2015036599.
LP634115 - Sequence 333 from Patent WO2015036599.
LP634119 - Sequence 337 from Patent WO2015036599.
LP634123 - Sequence 341 from Patent WO2015036599.
LP634127 - Sequence 345 from Patent WO2015036599.
LP634131 - Sequence 349 from Patent WO2015036599.
LP634135 - Sequence 353 from Patent WO2015036599.
LP634139 - Sequence 357 from Patent WO2015036599.
LP634143 - Sequence 361 from Patent WO2015036599.
LP634147 - Sequence 365 from Patent WO2015036599.
LP634151 - Sequence 369 from Patent WO2015036599.
LP634155 - Sequence 373 from Patent WO2015036599.
LP634159 - Sequence 377 from Patent WO2015036599.
LP634163 - Sequence 381 from Patent WO2015036599.
LP634167 - Sequence 385 from Patent WO2015036599.
LP634171 - Sequence 389 from Patent WO2015036599.
LP634175 - Sequence 393 from Patent WO2015036599.
LP634179 - Sequence 397 from Patent WO2015036599.
LP634183 - Sequence 401 from Patent WO2015036599.
LP634187 - Sequence 405 from Patent WO2015036599.
LP634191 - Sequence 409 from Patent WO2015036599.
LP634195 - Sequence 413 from Patent WO2015036599.
LP634199 - Sequence 417 from Patent WO2015036599.
LP634203 - Sequence 421 from Patent WO2015036599.
LP634207 - Sequence 425 from Patent WO2015036599.
LP634211 - Sequence 429 from Patent WO2015036599.
LP634215 - Sequence 433 from Patent WO2015036599.
LQ447458 - Sequence 293 from Patent EP3020727.
LQ447462 - Sequence 297 from Patent EP3020727.
LQ447466 - Sequence 301 from Patent EP3020727.
LQ447470 - Sequence 305 from Patent EP3020727.
LQ447474 - Sequence 309 from Patent EP3020727.
LQ447478 - Sequence 313 from Patent EP3020727.
LQ447482 - Sequence 317 from Patent EP3020727.
LQ447486 - Sequence 321 from Patent EP3020727.
LQ447490 - Sequence 325 from Patent EP3020727.
LQ447494 - Sequence 329 from Patent EP3020727.
LQ447498 - Sequence 333 from Patent EP3020727.
LQ447502 - Sequence 337 from Patent EP3020727.
LQ447506 - Sequence 341 from Patent EP3020727.
LQ447510 - Sequence 345 from Patent EP3020727.
LQ447514 - Sequence 349 from Patent EP3020727.
LQ447518 - Sequence 353 from Patent EP3020727.
LQ447522 - Sequence 357 from Patent EP3020727.
LQ447526 - Sequence 361 from Patent EP3020727.
LQ447530 - Sequence 365 from Patent EP3020727.
LQ447534 - Sequence 369 from Patent EP3020727.
LQ447538 - Sequence 373 from Patent EP3020727.
LQ447542 - Sequence 377 from Patent EP3020727.
LQ447546 - Sequence 381 from Patent EP3020727.
LQ447550 - Sequence 385 from Patent EP3020727.
LQ447554 - Sequence 389 from Patent EP3020727.
LQ447558 - Sequence 393 from Patent EP3020727.
LQ447562 - Sequence 397 from Patent EP3020727.
LQ447566 - Sequence 401 from Patent EP3020727.
LQ447570 - Sequence 405 from Patent EP3020727.
LQ447574 - Sequence 409 from Patent EP3020727.
LQ447578 - Sequence 413 from Patent EP3020727.
LQ447582 - Sequence 417 from Patent EP3020727.
LQ447586 - Sequence 421 from Patent EP3020727.
LQ447590 - Sequence 425 from Patent EP3020727.
LQ447594 - Sequence 429 from Patent EP3020727.
LQ447598 - Sequence 433 from Patent EP3020727.
LQ789460 - Sequence 293 from Patent EP3339318.
LQ789464 - Sequence 297 from Patent EP3339318.
LQ789468 - Sequence 301 from Patent EP3339318.
LQ789472 - Sequence 305 from Patent EP3339318.
LQ789476 - Sequence 309 from Patent EP3339318.
LQ789480 - Sequence 313 from Patent EP3339318.
LQ789484 - Sequence 317 from Patent EP3339318.
LQ789488 - Sequence 321 from Patent EP3339318.
LQ789492 - Sequence 325 from Patent EP3339318.
LQ789496 - Sequence 329 from Patent EP3339318.
LQ789500 - Sequence 333 from Patent EP3339318.
LQ789504 - Sequence 337 from Patent EP3339318.
LQ789508 - Sequence 341 from Patent EP3339318.
LQ789512 - Sequence 345 from Patent EP3339318.
LQ789516 - Sequence 349 from Patent EP3339318.
LQ789520 - Sequence 353 from Patent EP3339318.
LQ789524 - Sequence 357 from Patent EP3339318.
LQ789528 - Sequence 361 from Patent EP3339318.
LQ789532 - Sequence 365 from Patent EP3339318.
LQ789536 - Sequence 369 from Patent EP3339318.
LQ789540 - Sequence 373 from Patent EP3339318.
LQ789544 - Sequence 377 from Patent EP3339318.
LQ789548 - Sequence 381 from Patent EP3339318.
LQ789552 - Sequence 385 from Patent EP3339318.
LQ789556 - Sequence 389 from Patent EP3339318.
LQ789560 - Sequence 393 from Patent EP3339318.
LQ789564 - Sequence 397 from Patent EP3339318.
LQ789568 - Sequence 401 from Patent EP3339318.
LQ789572 - Sequence 405 from Patent EP3339318.
LQ789576 - Sequence 409 from Patent EP3339318.
LQ789580 - Sequence 413 from Patent EP3339318.
LQ789584 - Sequence 417 from Patent EP3339318.
LQ789588 - Sequence 421 from Patent EP3339318.
LQ789592 - Sequence 425 from Patent EP3339318.
LQ789596 - Sequence 429 from Patent EP3339318.
LQ789600 - Sequence 433 from Patent EP3339318.
LV525658 - JP 2016537012-A/220: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525661 - JP 2016537012-A/223: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525664 - JP 2016537012-A/226: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525667 - JP 2016537012-A/229: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525670 - JP 2016537012-A/232: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525673 - JP 2016537012-A/235: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525676 - JP 2016537012-A/238: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525679 - JP 2016537012-A/241: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525682 - JP 2016537012-A/244: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525685 - JP 2016537012-A/247: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525688 - JP 2016537012-A/250: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525691 - JP 2016537012-A/253: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525694 - JP 2016537012-A/256: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525697 - JP 2016537012-A/259: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525700 - JP 2016537012-A/262: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525703 - JP 2016537012-A/265: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525706 - JP 2016537012-A/268: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525709 - JP 2016537012-A/271: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525712 - JP 2016537012-A/274: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525715 - JP 2016537012-A/277: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525718 - JP 2016537012-A/280: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525721 - JP 2016537012-A/283: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525724 - JP 2016537012-A/286: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525727 - JP 2016537012-A/289: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525730 - JP 2016537012-A/292: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525733 - JP 2016537012-A/295: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525736 - JP 2016537012-A/298: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525739 - JP 2016537012-A/301: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525742 - JP 2016537012-A/304: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525745 - JP 2016537012-A/307: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525748 - JP 2016537012-A/310: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525751 - JP 2016537012-A/313: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525754 - JP 2016537012-A/316: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525757 - JP 2016537012-A/319: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525760 - JP 2016537012-A/322: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525763 - JP 2016537012-A/325: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289373 - KR 1020160068754-A/293: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289376 - KR 1020160068754-A/297: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289379 - KR 1020160068754-A/301: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289382 - KR 1020160068754-A/305: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289385 - KR 1020160068754-A/309: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289388 - KR 1020160068754-A/313: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289391 - KR 1020160068754-A/317: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289394 - KR 1020160068754-A/321: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289397 - KR 1020160068754-A/325: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289400 - KR 1020160068754-A/329: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289403 - KR 1020160068754-A/333: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289406 - KR 1020160068754-A/337: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289409 - KR 1020160068754-A/341: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289412 - KR 1020160068754-A/345: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289415 - KR 1020160068754-A/349: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289418 - KR 1020160068754-A/353: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289421 - KR 1020160068754-A/357: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289424 - KR 1020160068754-A/361: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289427 - KR 1020160068754-A/365: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289430 - KR 1020160068754-A/369: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289433 - KR 1020160068754-A/373: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289436 - KR 1020160068754-A/377: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289439 - KR 1020160068754-A/381: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289442 - KR 1020160068754-A/385: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289445 - KR 1020160068754-A/389: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289448 - KR 1020160068754-A/393: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289451 - KR 1020160068754-A/397: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289454 - KR 1020160068754-A/401: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289457 - KR 1020160068754-A/405: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289460 - KR 1020160068754-A/409: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289463 - KR 1020160068754-A/413: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289466 - KR 1020160068754-A/417: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289469 - KR 1020160068754-A/421: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289472 - KR 1020160068754-A/425: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289475 - KR 1020160068754-A/429: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289478 - KR 1020160068754-A/433: Mutant calreticulin for the diagnosis of myeloid malignancies.
LF373321 - JP 2014500723-A/180824: Polycomb-Associated Non-Coding RNAs.
LP633869 - Sequence 87 from Patent WO2015036599.
LP633885 - Sequence 103 from Patent WO2015036599.
LQ447252 - Sequence 87 from Patent EP3020727.
LQ447268 - Sequence 103 from Patent EP3020727.
LQ789254 - Sequence 87 from Patent EP3339318.
LQ789270 - Sequence 103 from Patent EP3339318.
LV525504 - JP 2016537012-A/66: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525516 - JP 2016537012-A/78: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289219 - KR 1020160068754-A/87: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289231 - KR 1020160068754-A/103: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633889 - Sequence 107 from Patent WO2015036599.
LQ447272 - Sequence 107 from Patent EP3020727.
LQ789274 - Sequence 107 from Patent EP3339318.
LV525519 - JP 2016537012-A/81: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289234 - KR 1020160068754-A/107: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633873 - Sequence 91 from Patent WO2015036599.
LQ447256 - Sequence 91 from Patent EP3020727.
LQ789258 - Sequence 91 from Patent EP3339318.
LV525507 - JP 2016537012-A/69: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289222 - KR 1020160068754-A/91: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633833 - Sequence 51 from Patent WO2015036599.
LQ447216 - Sequence 51 from Patent EP3020727.
LQ789218 - Sequence 51 from Patent EP3339318.
LV525477 - JP 2016537012-A/39: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289192 - KR 1020160068754-A/51: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633837 - Sequence 55 from Patent WO2015036599.
LQ447220 - Sequence 55 from Patent EP3020727.
LQ789222 - Sequence 55 from Patent EP3339318.
LV525480 - JP 2016537012-A/42: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289195 - KR 1020160068754-A/55: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633801 - Sequence 19 from Patent WO2015036599.
LP633841 - Sequence 59 from Patent WO2015036599.
LP633845 - Sequence 63 from Patent WO2015036599.
LQ447184 - Sequence 19 from Patent EP3020727.
LQ447224 - Sequence 59 from Patent EP3020727.
LQ447228 - Sequence 63 from Patent EP3020727.
LQ789186 - Sequence 19 from Patent EP3339318.
LQ789226 - Sequence 59 from Patent EP3339318.
LQ789230 - Sequence 63 from Patent EP3339318.
LV525453 - JP 2016537012-A/15: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525483 - JP 2016537012-A/45: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525486 - JP 2016537012-A/48: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289168 - KR 1020160068754-A/19: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289198 - KR 1020160068754-A/59: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289201 - KR 1020160068754-A/63: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633861 - Sequence 79 from Patent WO2015036599.
LQ447244 - Sequence 79 from Patent EP3020727.
LQ789246 - Sequence 79 from Patent EP3339318.
LV525498 - JP 2016537012-A/60: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289213 - KR 1020160068754-A/79: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633849 - Sequence 67 from Patent WO2015036599.
LQ447232 - Sequence 67 from Patent EP3020727.
LQ789234 - Sequence 67 from Patent EP3339318.
LV525489 - JP 2016537012-A/51: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289204 - KR 1020160068754-A/67: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633817 - Sequence 35 from Patent WO2015036599.
LP633853 - Sequence 71 from Patent WO2015036599.
LP633877 - Sequence 95 from Patent WO2015036599.
LQ447200 - Sequence 35 from Patent EP3020727.
LQ447236 - Sequence 71 from Patent EP3020727.
LQ447260 - Sequence 95 from Patent EP3020727.
LQ789202 - Sequence 35 from Patent EP3339318.
LQ789238 - Sequence 71 from Patent EP3339318.
LQ789262 - Sequence 95 from Patent EP3339318.
LV525465 - JP 2016537012-A/27: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525492 - JP 2016537012-A/54: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525510 - JP 2016537012-A/72: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289180 - KR 1020160068754-A/35: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289207 - KR 1020160068754-A/71: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289225 - KR 1020160068754-A/95: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633809 - Sequence 27 from Patent WO2015036599.
LQ447192 - Sequence 27 from Patent EP3020727.
LQ789194 - Sequence 27 from Patent EP3339318.
LV525459 - JP 2016537012-A/21: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289174 - KR 1020160068754-A/27: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633829 - Sequence 47 from Patent WO2015036599.
LQ447212 - Sequence 47 from Patent EP3020727.
LQ789214 - Sequence 47 from Patent EP3339318.
LV525474 - JP 2016537012-A/36: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289189 - KR 1020160068754-A/47: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633821 - Sequence 39 from Patent WO2015036599.
LP633857 - Sequence 75 from Patent WO2015036599.
LP633881 - Sequence 99 from Patent WO2015036599.
LQ447204 - Sequence 39 from Patent EP3020727.
LQ447240 - Sequence 75 from Patent EP3020727.
LQ447264 - Sequence 99 from Patent EP3020727.
LQ789206 - Sequence 39 from Patent EP3339318.
LQ789242 - Sequence 75 from Patent EP3339318.
LQ789266 - Sequence 99 from Patent EP3339318.
LV525468 - JP 2016537012-A/30: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525495 - JP 2016537012-A/57: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525513 - JP 2016537012-A/75: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289183 - KR 1020160068754-A/39: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289210 - KR 1020160068754-A/75: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289228 - KR 1020160068754-A/99: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633805 - Sequence 23 from Patent WO2015036599.
LQ447188 - Sequence 23 from Patent EP3020727.
LQ789190 - Sequence 23 from Patent EP3339318.
LV525456 - JP 2016537012-A/18: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289171 - KR 1020160068754-A/23: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633797 - Sequence 15 from Patent WO2015036599.
LQ447180 - Sequence 15 from Patent EP3020727.
LQ789182 - Sequence 15 from Patent EP3339318.
LV525450 - JP 2016537012-A/12: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289165 - KR 1020160068754-A/15: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633865 - Sequence 83 from Patent WO2015036599.
LQ447248 - Sequence 83 from Patent EP3020727.
LQ789250 - Sequence 83 from Patent EP3339318.
LV525501 - JP 2016537012-A/63: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289216 - KR 1020160068754-A/83: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633789 - Sequence 7 from Patent WO2015036599.
LQ447172 - Sequence 7 from Patent EP3020727.
LQ789174 - Sequence 7 from Patent EP3339318.
LV525444 - JP 2016537012-A/6: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289159 - KR 1020160068754-A/7: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633897 - Sequence 115 from Patent WO2015036599.
LQ447280 - Sequence 115 from Patent EP3020727.
LQ789282 - Sequence 115 from Patent EP3339318.
LV525525 - JP 2016537012-A/87: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289240 - KR 1020160068754-A/115: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633813 - Sequence 31 from Patent WO2015036599.
LP633893 - Sequence 111 from Patent WO2015036599.
LQ447196 - Sequence 31 from Patent EP3020727.
LQ447276 - Sequence 111 from Patent EP3020727.
LQ789198 - Sequence 31 from Patent EP3339318.
LQ789278 - Sequence 111 from Patent EP3339318.
LV525462 - JP 2016537012-A/24: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525522 - JP 2016537012-A/84: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289177 - KR 1020160068754-A/31: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289237 - KR 1020160068754-A/111: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633793 - Sequence 11 from Patent WO2015036599.
LP633825 - Sequence 43 from Patent WO2015036599.
LP633901 - Sequence 119 from Patent WO2015036599.
LP633905 - Sequence 123 from Patent WO2015036599.
LP633909 - Sequence 127 from Patent WO2015036599.
LP633913 - Sequence 131 from Patent WO2015036599.
LP633917 - Sequence 135 from Patent WO2015036599.
LP633921 - Sequence 139 from Patent WO2015036599.
LP633925 - Sequence 143 from Patent WO2015036599.
LQ447176 - Sequence 11 from Patent EP3020727.
LQ447208 - Sequence 43 from Patent EP3020727.
LQ447284 - Sequence 119 from Patent EP3020727.
LQ447288 - Sequence 123 from Patent EP3020727.
LQ447292 - Sequence 127 from Patent EP3020727.
LQ447296 - Sequence 131 from Patent EP3020727.
LQ447300 - Sequence 135 from Patent EP3020727.
LQ447304 - Sequence 139 from Patent EP3020727.
LQ447308 - Sequence 143 from Patent EP3020727.
LQ789178 - Sequence 11 from Patent EP3339318.
LQ789210 - Sequence 43 from Patent EP3339318.
LQ789286 - Sequence 119 from Patent EP3339318.
LQ789290 - Sequence 123 from Patent EP3339318.
LQ789294 - Sequence 127 from Patent EP3339318.
LQ789298 - Sequence 131 from Patent EP3339318.
LQ789302 - Sequence 135 from Patent EP3339318.
LQ789306 - Sequence 139 from Patent EP3339318.
LQ789310 - Sequence 143 from Patent EP3339318.
LV525447 - JP 2016537012-A/9: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525471 - JP 2016537012-A/33: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525528 - JP 2016537012-A/90: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525531 - JP 2016537012-A/93: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525534 - JP 2016537012-A/96: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525537 - JP 2016537012-A/99: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525540 - JP 2016537012-A/102: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525543 - JP 2016537012-A/105: Mutant calreticulin for the diagnosis of myeloid malignancies.
LV525546 - JP 2016537012-A/108: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289162 - KR 1020160068754-A/11: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289186 - KR 1020160068754-A/43: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289243 - KR 1020160068754-A/119: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289246 - KR 1020160068754-A/123: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289249 - KR 1020160068754-A/127: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289252 - KR 1020160068754-A/131: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289255 - KR 1020160068754-A/135: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289258 - KR 1020160068754-A/139: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289261 - KR 1020160068754-A/143: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP633785 - Sequence 3 from Patent WO2015036599.
LQ447168 - Sequence 3 from Patent EP3020727.
LQ789170 - Sequence 3 from Patent EP3339318.
LV525441 - JP 2016537012-A/3: Mutant calreticulin for the diagnosis of myeloid malignancies.
LY289156 - KR 1020160068754-A/3: Mutant calreticulin for the diagnosis of myeloid malignancies.
LP886335 - Sequence 227 from Patent WO2017201352.
LP978092 - Sequence 227 from Patent WO2017120612.
LF373320 - JP 2014500723-A/180823: Polycomb-Associated Non-Coding RNAs.
JD188581 - Sequence 169605 from Patent EP1572962.
JD301211 - Sequence 282235 from Patent EP1572962.
JD253562 - Sequence 234586 from Patent EP1572962.
LF373319 - JP 2014500723-A/180822: Polycomb-Associated Non-Coding RNAs.
JD500697 - Sequence 481721 from Patent EP1572962.
LF373318 - JP 2014500723-A/180821: Polycomb-Associated Non-Coding RNAs.
JD282117 - Sequence 263141 from Patent EP1572962.
JD093780 - Sequence 74804 from Patent EP1572962.
JD555838 - Sequence 536862 from Patent EP1572962.
JD205734 - Sequence 186758 from Patent EP1572962.
JD307552 - Sequence 288576 from Patent EP1572962.
JD390596 - Sequence 371620 from Patent EP1572962.
LF373317 - JP 2014500723-A/180820: Polycomb-Associated Non-Coding RNAs.
JD316211 - Sequence 297235 from Patent EP1572962.
LQ980367 - Sequence 13 from Patent WO2013050532.
MA608909 - JP 2018138019-A/180835: Polycomb-Associated Non-Coding RNAs.
MA608908 - JP 2018138019-A/180834: Polycomb-Associated Non-Coding RNAs.
MA608906 - JP 2018138019-A/180832: Polycomb-Associated Non-Coding RNAs.
MA608905 - JP 2018138019-A/180831: Polycomb-Associated Non-Coding RNAs.
MA608904 - JP 2018138019-A/180830: Polycomb-Associated Non-Coding RNAs.
MA608903 - JP 2018138019-A/180829: Polycomb-Associated Non-Coding RNAs.
MA608902 - JP 2018138019-A/180828: Polycomb-Associated Non-Coding RNAs.
MA608901 - JP 2018138019-A/180827: Polycomb-Associated Non-Coding RNAs.
MA608900 - JP 2018138019-A/180826: Polycomb-Associated Non-Coding RNAs.
MA608899 - JP 2018138019-A/180825: Polycomb-Associated Non-Coding RNAs.
MA608898 - JP 2018138019-A/180824: Polycomb-Associated Non-Coding RNAs.
MA608897 - JP 2018138019-A/180823: Polycomb-Associated Non-Coding RNAs.
MA608896 - JP 2018138019-A/180822: Polycomb-Associated Non-Coding RNAs.
MA608895 - JP 2018138019-A/180821: Polycomb-Associated Non-Coding RNAs.
MA608894 - JP 2018138019-A/180820: Polycomb-Associated Non-Coding RNAs.
MA443761 - JP 2018138019-A/15687: Polycomb-Associated Non-Coding RNAs.
MP273754 - Sequence 267 from Patent EP3494985.
MP273758 - Sequence 271 from Patent EP3494985.
MP273762 - Sequence 275 from Patent EP3494985.
MP273766 - Sequence 279 from Patent EP3494985.
MP273770 - Sequence 283 from Patent EP3494985.
MP273774 - Sequence 287 from Patent EP3494985.
MP273780 - Sequence 293 from Patent EP3494985.
MP273784 - Sequence 297 from Patent EP3494985.
MP273788 - Sequence 301 from Patent EP3494985.
MP273792 - Sequence 305 from Patent EP3494985.
MP273796 - Sequence 309 from Patent EP3494985.
MP273800 - Sequence 313 from Patent EP3494985.
MP273804 - Sequence 317 from Patent EP3494985.
MP273808 - Sequence 321 from Patent EP3494985.
MP273812 - Sequence 325 from Patent EP3494985.
MP273816 - Sequence 329 from Patent EP3494985.
MP273820 - Sequence 333 from Patent EP3494985.
MP273824 - Sequence 337 from Patent EP3494985.
MP273828 - Sequence 341 from Patent EP3494985.
MP273832 - Sequence 345 from Patent EP3494985.
MP273836 - Sequence 349 from Patent EP3494985.
MP273840 - Sequence 353 from Patent EP3494985.
MP273844 - Sequence 357 from Patent EP3494985.
MP273848 - Sequence 361 from Patent EP3494985.
MP273852 - Sequence 365 from Patent EP3494985.
MP273856 - Sequence 369 from Patent EP3494985.
MP273860 - Sequence 373 from Patent EP3494985.
MP273864 - Sequence 377 from Patent EP3494985.
MP273868 - Sequence 381 from Patent EP3494985.
MP273872 - Sequence 385 from Patent EP3494985.
MP273876 - Sequence 389 from Patent EP3494985.
MP273880 - Sequence 393 from Patent EP3494985.
MP273884 - Sequence 397 from Patent EP3494985.
MP273888 - Sequence 401 from Patent EP3494985.
MP273892 - Sequence 405 from Patent EP3494985.
MP273896 - Sequence 409 from Patent EP3494985.
MP273900 - Sequence 413 from Patent EP3494985.
MP273904 - Sequence 417 from Patent EP3494985.
MP273908 - Sequence 421 from Patent EP3494985.
MP273912 - Sequence 425 from Patent EP3494985.
MP273916 - Sequence 429 from Patent EP3494985.
MP273920 - Sequence 433 from Patent EP3494985.
MP273634 - Sequence 147 from Patent EP3494985.
MP273638 - Sequence 151 from Patent EP3494985.
MP273642 - Sequence 155 from Patent EP3494985.
MP273646 - Sequence 159 from Patent EP3494985.
MP273650 - Sequence 163 from Patent EP3494985.
MP273654 - Sequence 167 from Patent EP3494985.
MP273658 - Sequence 171 from Patent EP3494985.
MP273662 - Sequence 175 from Patent EP3494985.
MP273666 - Sequence 179 from Patent EP3494985.
MP273670 - Sequence 183 from Patent EP3494985.
MP273674 - Sequence 187 from Patent EP3494985.
MP273678 - Sequence 191 from Patent EP3494985.
MP273682 - Sequence 195 from Patent EP3494985.
MP273686 - Sequence 199 from Patent EP3494985.
MP273690 - Sequence 203 from Patent EP3494985.
MP273694 - Sequence 207 from Patent EP3494985.
MP273698 - Sequence 211 from Patent EP3494985.
MP273702 - Sequence 215 from Patent EP3494985.
MP273706 - Sequence 219 from Patent EP3494985.
MP273710 - Sequence 223 from Patent EP3494985.
MP273714 - Sequence 227 from Patent EP3494985.
MP273718 - Sequence 231 from Patent EP3494985.
MP273722 - Sequence 235 from Patent EP3494985.
MP273726 - Sequence 239 from Patent EP3494985.
MP273730 - Sequence 243 from Patent EP3494985.
MP273734 - Sequence 247 from Patent EP3494985.
MP273738 - Sequence 251 from Patent EP3494985.
MP273742 - Sequence 255 from Patent EP3494985.
MP273746 - Sequence 259 from Patent EP3494985.
MP273750 - Sequence 263 from Patent EP3494985.
MP273574 - Sequence 87 from Patent EP3494985.
MP273590 - Sequence 103 from Patent EP3494985.
MP273594 - Sequence 107 from Patent EP3494985.
MP273578 - Sequence 91 from Patent EP3494985.
MP273538 - Sequence 51 from Patent EP3494985.
MP273542 - Sequence 55 from Patent EP3494985.
MP273506 - Sequence 19 from Patent EP3494985.
MP273546 - Sequence 59 from Patent EP3494985.
MP273550 - Sequence 63 from Patent EP3494985.
MP273566 - Sequence 79 from Patent EP3494985.
MP273554 - Sequence 67 from Patent EP3494985.
MP273522 - Sequence 35 from Patent EP3494985.
MP273558 - Sequence 71 from Patent EP3494985.
MP273582 - Sequence 95 from Patent EP3494985.
MP273514 - Sequence 27 from Patent EP3494985.
MP273534 - Sequence 47 from Patent EP3494985.
MP273526 - Sequence 39 from Patent EP3494985.
MP273562 - Sequence 75 from Patent EP3494985.
MP273586 - Sequence 99 from Patent EP3494985.
MP273510 - Sequence 23 from Patent EP3494985.
MP273502 - Sequence 15 from Patent EP3494985.
MP273570 - Sequence 83 from Patent EP3494985.
MP273494 - Sequence 7 from Patent EP3494985.
MP273602 - Sequence 115 from Patent EP3494985.
MP273518 - Sequence 31 from Patent EP3494985.
MP273598 - Sequence 111 from Patent EP3494985.
MP273498 - Sequence 11 from Patent EP3494985.
MP273530 - Sequence 43 from Patent EP3494985.
MP273606 - Sequence 119 from Patent EP3494985.
MP273610 - Sequence 123 from Patent EP3494985.
MP273614 - Sequence 127 from Patent EP3494985.
MP273618 - Sequence 131 from Patent EP3494985.
MP273622 - Sequence 135 from Patent EP3494985.
MP273626 - Sequence 139 from Patent EP3494985.
MP273630 - Sequence 143 from Patent EP3494985.
MP273490 - Sequence 3 from Patent EP3494985.
MB419114 - JP 2019519516-A/76: MRNA COMBINATION THERAPIES FOR THE TREATMENT OF CANCER.
MB419979 - JP 2019519516-A/941: MRNA COMBINATION THERAPIES FOR THE TREATMENT OF CANCER.

BioCarta from NCI Cancer Genome Anatomy Project
h_nfatPathway - NFAT and Hypertrophy of the heart (Transcription in the broken heart)

Alternate Gene Symbols: ENST00000316448.1, ENST00000316448.2, ENST00000316448.3, ENST00000316448.4, ENST00000316448.5, ENST00000316448.6, ENST00000316448.7, ENST00000316448.8, ENST00000316448.9, HEL-S-99n , NM_004343, uc317qai.1, uc317qai.2, V9HW88, V9HW88_HUMAN
UCSC ID: ENST00000316448.10_6
RefSeq Accession: NM_004343.4

Click here for a detailed description of the fields of the table above.

Click here for details on how this gene model was made and data restrictions if any.